top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances in the Treatment of Renal Cell Carcinoma
Advances in the Treatment of Renal Cell Carcinoma
Autore Reynolds Paul
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (221 p.)
Soggetto topico Medicine
Soggetto non controllato renal cell carcinoma
autophagy
hydroxychloroquine
chloroquine
ROC-325
cysteine cathepsins
cysteine cathepsin inhibitors
lysosome
renal cancer
metastatic renal cell carcinoma
immune-based combination therapies
network meta-analysis
PD-L1
predictive
biomarker
treatment
TKIs
mRCC
biomarkers
soluble factors
immunotherapy
renal cell carcinoma (RCC)
sunitib resistance
artesunate (ART)
Traditional Chinese Medicine (TCM)
growth inhibition
ferroptosis
reactive oxygen species (ROS)
clear cell renal cell carcinoma
ccRCC
RCC
kidney cancer
evolution
evolutionary trajectory
metastatic
second line therapy
renal cell cancer
immune checkpoint inhibitors
tyrosine kinase inhibitors
individualization
genomic signature
transcriptomic analysis
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557615503321
Reynolds Paul  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cancer Biomarker Research and Personalized Medicine
Cancer Biomarker Research and Personalized Medicine
Autore Meehan James
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (428 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato clear cell renal cell carcinoma
radiomics
WHO/ISUP nuclear grade
multiphasic multidetector computed tomography
triple-negative breast cancer
taxane
chemotherapy
GBP5
Akt/mTOR
autophagy
IL13Rα2
renal cell carcinoma
JAK2
FOXO3
telmisartan
ovarian cancer
bioinformatics
CREB1
drug perturbation
lincRNA-p21
rectal cancer
chemoradiotherapy
colorectal cancer
long non-coding RNA
p53
predictive biomarker
intestinal anastomosis
anastomotic leak
biomarkers
precision medicine
personalized medicine
biomarker
AmpliSeq
DNA methylation
epigenetics
head and neck cancer
saliva
liquid biopsy
meta-analysis
gastric cancer
middle-up-down
haptoglobin
glycopeptide
mass spectrometry
circulating tumor cells
prostate cancer
cancer vaccine
immune response
breast cancer
predictive tools
prognostic tools
translational research
IL6ST
gp130
cytokine signalling
tissue-based biomarkers
liquid-based biomarkers
radiotherapy
radiosensitivity biomarkers
secretome
radioresistance
bladder tumor
lymphocyte-to-monocyte ratio
peripheral blood parameters
tumor recurrence
transurethral resection
lipidomics
1H-NMR
LC-MS/MS
lipoprotein subfractions
lipoprotein lipase
cancer biomarkers
hepatocellular carcinoma
p16 expression
head and neck squamous cell carcinoma
HPV genotyping
exosomes
chemoresistance
comparative oncology
One Health
microRNA
lymph node metastasis
hormone-dependent carcinogenesis
localized prostate cancer
prognostic factors
HNSCC
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910674370003321
Meehan James  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrating Clinical and Translational Research Networks-Building Team Medicine
Integrating Clinical and Translational Research Networks-Building Team Medicine
Autore Salgia Ravi
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (250 p.)
Soggetto topico Medicine
Soggetto non controllato renal cell carcinoma
team medicine
translational research
community practice
clinical trials
geriatric oncology
older adults
cancer clinical trials
recruitment
community
team science
bladder cancer
urothelial carcinoma
COVID-19
team-based medicine
colorectal cancer
precisian medicine
academic and community oncology
cancer center
lung cancer
lung cancer screening
low-dose CT scans
cancer prevention
smoking cessation
tobacco control
national guidelines for screening and prevention
pharmaceutical aids to smoking cessation
non-small cell lung cancer
driver mutations
testing rates
receptor tyrosine kinases
actionable mutations
next-generation sequencing
fast-and-frugal trees
personalized medicine
minorities
ethnicity
race
breast cancer
research
HER2-directed therapy
community oncology
academic cancer center
precision medicine
cancer genetics
cancer genomics
small cell lung cancer
immunotherapy
epithelial ovarian cancer
frontline treatment
surgical debulking
adjuvant chemotherapy
maintenance therapy
PARP inhibitor
genetics counseling
clinical research
oropharyngeal cancer
concurrent chemoradiation therapy
human papillomavirus
feeding tube dependency
value-based care
value-based cancer care
oncology pathways
Early Recovery After Surgery (ERAS)
team-based care
oncology medical home
integrated cancer care
supportive care pathways
surgical pathways
cancer care plans
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557124403321
Salgia Ravi  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Kidney Inflammation, Injury and Regeneration
Kidney Inflammation, Injury and Regeneration
Autore Koch Benjamin
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (496 p.)
Soggetto non controllato microRNAs
transcription
ischemia/reperfusion injury
DSS-colitis
kidney inflammation
therapeutics targets
CXCL13
glomerulus
interleukin-6
rhabdomyolysis
IgA nephropathy
CREB Regulated Transcriptional Coactivators (CRTC)
slit diaphragm
injury
xanthine oxidase
Salt Inducible Kinase (SIK)
acute and chronic kidney disease
therapeutic target
KIT-IgA score
G-protein-coupled bile acid receptor (TGR5)
lysophosphatidic acid
glomerular injury
IL-18
mesenchymal stem cells
Taiwan
acute kidney injury
renal ischemia-reperfusion
long non-coding RNA
fibrosis
acute kidney failure
diabetic kidney diseases
chronic kidney disease
lncRNA
LPS-binding protein
endotoxemia-induced oliguric kidney injury
dapagliflozin
cPLA2 and COX-2
NLRP3 inflammasome
CmklR1
haem
chronic kidney injury
omega-3 fatty acid
noninvasive
inflammation
regulated necrosis
GLP-1 receptor agonists
miRNA
AKI
SGLT2 inhibitors
diabetic kidney disease
extracellular vesicles
podocin
type IV collagen
epithelial cells
nephrin
2-kidney-1-clip
renal fibrosis
papilla
diagnostics
necrosis
non-coding RNAs
podocyte
Thy1.1 nephritis
KIT assay
oxidative stress
conditioned medium
C-reactive protein
pericyte
myofibroblast
Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-?B)
endotoxemia
modifier gene
polymorphism
renal stem cells
kidney
polyploidization
Class IIa Histone Deacetylases (HDAC)
2k1c
molecular signaling
proximal tubule
arachidonic acid
empagliflozin
tubular injury
signaling cascade
signal transduction
inflammatory maker
niches
biomarkers
renal progenitors
type V collagen
cyclooxygenase
focal segmental glomerulosclerosis
inflammatory bowel disease (IBD)
chronic kidney disease (CKD)
allograft rejection
renovascular hypertension
genotype
molecular mechanisms
ROS
prediction
glomerular filtration barrier (GFB)
alport syndrome
scattered tubular cells
long non-coding RNAs
renal inflammation
lysophosphatidic acid receptor
cAMP Regulatory Element Binding Protein (CREB)
Farnesiferol B
differentiation
mesenchymal stromal cells
modified-MSCs
kidney transplantation
polyunsaturated fatty acids
apoptosis
type I collagen
diabetes mellitus
natural products
lipoxygenase
stem cell
T cell-mediated rejection
exosomes
renal injury
obese kidney fibrosis
kidney injury
cytotoxicity
mesenchymal stem cell
pigment nephropathy
mesodermal stem cell
ischemia-reperfusion
cytochrome P450
renal cell carcinoma
hematuria
B-cell attracting chemokine
microRNA
chemerin
glomerular basement membrane
glomerular damage
renal tubular cells
kidney proximal tubule
exosome
hypertension
diabetic nephropathy
ISBN 3-03928-539-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404091203321
Koch Benjamin  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Minimally Invasive Urological Procedures and Related Technological Developments
Minimally Invasive Urological Procedures and Related Technological Developments
Autore Somani Bhaskar K
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (142 p.)
Soggetto topico Medicine
Surgery
Soggetto non controllato partial nephrectomy
single site surgery
sutureless
CEUS
contrast-enhanced ultrasound
renal ultrasound
image quality
small renal mass (3–5)
kidney stones
metabolic syndrome
urolithiasis
nephrolithiasis
kidney calculi
diabetes mellitus
acute kidney injury
percutaneous nephrolithotomy
urology
artificial intelligence
machine learning
urinary incontinence
kidney stone disease
fertility
reproductive urology
renal cell carcinoma
hydronephrosis
urinary reflux
endourology
pediatric urology
prostate cancer
bladder cancer
nephrostomy
quality of life
survival
decision making
ureteroscopy
laser
RIRS
Moses
holmium
mineral water
mineral composition
drinking water
still water
sparkling water
Ho:YAG laser
thulium fiber laser
laser fiber
lithotripsy
chronic prostatitis
chronic pelvic pain syndrome
extracorporeal shockwave therapy
ESWT
NIH-CPSI
EHS
IIEF-5
QoL
urosepsis
laser lithotripsy
predictor factors
PCNL
renal tumour
AI
TFL
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557353203321
Somani Bhaskar K  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Natural Compounds as New Cancer Treatments
Natural Compounds as New Cancer Treatments
Autore Barrajon Enrique
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (128 p.)
Soggetto non controllato microbiota
treatment
sulforaphane
synergy
epigenetic
natural compound
xenohormesis
anticancer
miR-663
tyrosine kinase inhibitors
acetylation
epidemiology
double-blinded
inflammation
bladder cancer
polypharmacology
animal model
synbiotics
resveratrol
royal jelly
5-aza-2'-deoxycytine
saponins
phenolics
cardiovascular disease
antioxidant
colorectal cancer
trypsin inhibitors
seeds
green tea
Gac
randomized clinical trial
melanoma
adverse events
extraction
microbiome
Momordica cochinchinensis
freeze dried extract
renal cell carcinoma
methylation
cancer
probiotics
ISBN 3-03921-366-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367758003321
Barrajon Enrique  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances and Clinical Outcomes of Kidney Transplantation : Volume 2
Recent Advances and Clinical Outcomes of Kidney Transplantation : Volume 2
Autore Cheungpasitporn Wisit
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (270 p.)
Soggetto topico Medicine
Soggetto non controllato malondialdehyde
oxidative stress
new-onset diabetes
renal transplantation
BK virus
BK virus nephropathy
kidney allograft
transplantation
Alport syndrome
children
autosomal dominant polycystic kidney disease
epidemiology
hospitalization
kidney transplantation
subarachnoid hemorrhage
malignancy
post-transplant malignancy
renal cell carcinoma
meta-analysis
systematic reviews
tacrolimus
C/D-ratio
pharmacokinetics
opportunistic infection
allograft survival
urological complications
ureteric stent
urinary tract infection
timing of removal
living donor
ethnicity
age
obesity
genetic relationship donor/recipient
atypical hemolytic uremic syndrome
eculizumab
glucose intolerance
insulin secretion
insulin resistance
oral glucose tolerance test
healthy subject
hyperchloremia
kidney graft dysfunction
living donor kidney transplantation
Uropathogenic E. coli
UPEC
phylogeny
genomics
antibiotic resistance
virulence traits
night-time renal transplantation
graft survival
patient survival/outcome
surgical complications
acute rejection
lymphocyte
CD45RC
Belatacept
cardiovascular high risk
outcome
machine perfusion
organ preservation
temperature
hypothermic
normothermic
transplant
proton-pump inhibitors
iron
iron deficiency
polyomavirus
BKV
kidney
glomerulus
BKVAN
nephropathy
fluid management
delayed graft function
goal-directed fluid therapy
calcineurin inhibitor nephrotoxcity
C/D ratio
tacrolimus metabolism
ADPKD
native nephrectomy
patient outcome
perioperative complications
epidermal growth factor
creatinine
graft failure
new onset diabetes after renal transplantation
single nucleotide polymorphisms
urinary biomarkers
α-GST
π-GST
nephrotoxicity
urinary excretion of N1-methylnicotinamide
mortality
niacin status
dietary intake
tryptophan
vitamin B3
Kidney transplant
vitamin C
cancer mortality
mycophenolic acid
immunosuppression
plasmapheresis
oxalate
hyperoxaluria
kidney transplant recipients
post-transplantation diabetes mellitus
all-cause mortality
cardiovascular mortality
infectious mortality
magnesium
hypomagnesaemia
cancer
kidney transplant
survival
living kidney donation
living-donor kidney transplantation
beliefs
inequity
ischemia reperfusion injury
innate immune system
adaptive immune system
apoptosis
necrosis
hypoxic inducible factor
endothelial dysfunction
proton pump inhibitor
transplant rejection
GFR
insulin-like growth factor 1
growth hormone
muscle mass
patient survival
physical activity
renal transplant recipients
kidney transplant (KT)
donor-specific antibodies (DSA)
C3d-binding assay
antibody-mediated rejection (AMR)
arsenic
diet
fish consumption
post-transplant diabetes mellitus
N1-methyl-2-pyridone-5-carboxamide
N1-methylnicotinamide
urinary excretion
kidney function
biomarker
branched chain amino acids
posttransplant diarrhea
methanogenesis
Methanosphaera stadtmanae
mucins
sulfate-reducing bacteria
acute humoral rejection
first-line therapy
outcomes
proteasome inhibitor
renal transplant
transplant recipients
calcineurin inhibitors
FK506
pharmacokinetic
fast tacrolimus metabolizers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Recent Advances and Clinical Outcomes of Kidney Transplantation
Record Nr. UNINA-9910557787303321
Cheungpasitporn Wisit  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances and Clinical Outcomes of Kidney Transplantation
Recent Advances and Clinical Outcomes of Kidney Transplantation
Autore Cheungpasitporn Wisit
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (342 p.)
Soggetto topico Medicine
Soggetto non controllato malondialdehyde
oxidative stress
new-onset diabetes
renal transplantation
BK virus
BK virus nephropathy
kidney allograft
transplantation
Alport syndrome
children
autosomal dominant polycystic kidney disease
epidemiology
hospitalization
kidney transplantation
subarachnoid hemorrhage
malignancy
post-transplant malignancy
renal cell carcinoma
meta-analysis
systematic reviews
tacrolimus
C/D-ratio
pharmacokinetics
opportunistic infection
allograft survival
urological complications
ureteric stent
urinary tract infection
timing of removal
living donor
ethnicity
age
obesity
genetic relationship donor/recipient
atypical hemolytic uremic syndrome
eculizumab
glucose intolerance
insulin secretion
insulin resistance
oral glucose tolerance test
healthy subject
hyperchloremia
kidney graft dysfunction
living donor kidney transplantation
Uropathogenic E. coli
UPEC
phylogeny
genomics
antibiotic resistance
virulence traits
night-time renal transplantation
graft survival
patient survival/outcome
surgical complications
acute rejection
lymphocyte
CD45RC
Belatacept
cardiovascular high risk
outcome
machine perfusion
organ preservation
temperature
hypothermic
normothermic
transplant
proton-pump inhibitors
iron
iron deficiency
polyomavirus
BKV
kidney
glomerulus
BKVAN
nephropathy
fluid management
delayed graft function
goal-directed fluid therapy
calcineurin inhibitor nephrotoxcity
C/D ratio
tacrolimus metabolism
ADPKD
native nephrectomy
patient outcome
perioperative complications
epidermal growth factor
creatinine
graft failure
new onset diabetes after renal transplantation
single nucleotide polymorphisms
urinary biomarkers
α-GST
π-GST
nephrotoxicity
urinary excretion of N1-methylnicotinamide
mortality
niacin status
dietary intake
tryptophan
vitamin B3
Kidney transplant
vitamin C
cancer mortality
mycophenolic acid
immunosuppression
plasmapheresis
oxalate
hyperoxaluria
kidney transplant recipients
post-transplantation diabetes mellitus
all-cause mortality
cardiovascular mortality
infectious mortality
magnesium
hypomagnesaemia
cancer
kidney transplant
survival
living kidney donation
living-donor kidney transplantation
beliefs
inequity
ischemia reperfusion injury
innate immune system
adaptive immune system
apoptosis
necrosis
hypoxic inducible factor
endothelial dysfunction
proton pump inhibitor
transplant rejection
GFR
insulin-like growth factor 1
growth hormone
muscle mass
patient survival
physical activity
renal transplant recipients
kidney transplant (KT)
donor-specific antibodies (DSA)
C3d-binding assay
antibody-mediated rejection (AMR)
arsenic
diet
fish consumption
post-transplant diabetes mellitus
N1-methyl-2-pyridone-5-carboxamide
N1-methylnicotinamide
urinary excretion
kidney function
biomarker
branched chain amino acids
posttransplant diarrhea
methanogenesis
Methanosphaera stadtmanae
mucins
sulfate-reducing bacteria
acute humoral rejection
first-line therapy
outcomes
proteasome inhibitor
renal transplant
transplant recipients
calcineurin inhibitors
FK506
pharmacokinetic
fast tacrolimus metabolizers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557632603321
Cheungpasitporn Wisit  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Recent Advances in Pancreatic Neoplasms
Recent Advances in Pancreatic Neoplasms
Autore Sperti Cosimo
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (176 p.)
Soggetto topico Medicine
Oncology
Soggetto non controllato PIWI proteins
PIWIL3
PIWIL4
pancreatic cancer
EMT
chemoresistance
motility
HNF4A
survival
pancreatic neuroendocrine neoplasm
primary pancreatic carcinoid
serotonin-secreting pancreatic tumour
serotonin-producing pancreatic tumour
neoadjuvant chemotherapy
response
carbohydrate antigen 19-9
fluorodeoxyglucose
pancreatectomy
positron emission tomography
prognosis
standardized uptake value
Pancreatic ductal adenocarcinoma
microRNAs
pancreatic fistula
pancreatic neoplasm
renal cell carcinoma
pancreatic neoplasms
PET-CT scan
pancreatic ductal adenocarcinoma
pancreatic cancer prognosis
completion total pancreatectomy
pooled analysis
recurrent pancreatic cancer
repeated pancreatectomy
pancreas
neuropathy
taxanes
biomarker
C-reactive protein to albumin ratio
inflammation
intraductal papillary mucinous neoplasm
modified Glasgow prognostic score
neutrophyl lymphocite ratio
platelet-to-lymphocyte ratio
robotic pancreatic surgery
pancreato-gastrostomy
low muscle mass
sarcopenia
pancreatic adenocarcinoma
pancreatic surgery
body composition
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566480103321
Sperti Cosimo  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Renal Cell Carcinoma
Renal Cell Carcinoma
Autore López José I
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (500 p.)
Soggetto topico Renal cell carcinoma
Kidneys - Cancer
Soggetto non controllato N-glycomapping
SMAD proteins
patient survival
pro-IL-1?
survival prediction
inflammation markers
tumor migration
prognostic factors
practical approach
circular RNAs in a clinico-genomic predictive model
glycomarkers
review
nephrectomy
uric acid
VEGF inhibitors
metabolic reprogramming
collecting duct carcinoma
curcumin
metabolome profiling
identification of circular RNAs
IL-2
experimental validation of circular RNA
Raf/MEK/ERK
HOT
PI3K/Akt/mTOR
pentose phosphate pathway
kidney cancer
LOT
mutation
RCC
polybromo-1
pale cell
MMP-9
gene expression
recurrence free survival
chromosomal loss
IL-1?
chronic kidney disease
glutathione transferase omega 2
label-free
glutathione transferase omega 1
emerging entity
copy number alteration
FOXO3
predictive role
tumor slice culture
tyrosine kinase inhibitors
PPP
ESC
CDKN1A expression
metastasis
PD-L1
diagnostic and prognostic markers
EVI1
copy number loss
RNA sequencing
NK cells
glutathione metabolism
clear cell renal cell carcinoma
renal cell cancer
proliferation
eosinophilic variant
Xp11 translocation renal cell carcinoma
prognosis
invasion
immune infiltration
IL4R?
FISH
11) translocation renal cell carcinoma
tumor microenvironment
metabolome
hyperosmolality
toxicity
ALK
drug sensitivity
t(6
copy number analysis
urine
genetic association
polymorphism
solute carrier proteins
kidney
metastatic ccRCC
molecular genetic features
recurrence-free survival
chromophobe renal cell carcinoma
unclassified renal tumor
overall survival
mTOR inhibitors
mTOR
JAK2
von Hippel-Lindau
miR-155-5p
glycoproteomics
PBRM1
miR-133b
survival
TFE3
TFEB
oncocytic renal tumor
immune checkpoint inhibitors
biomarker
MMP10
TCGA
ghrelin
EMT like
checkpoint inhibitors
MiT family translocation renal cell carcinoma
gene signature
sarcomatoid
transforming growth factor beta
clear cell Renal Cell Carcinoma
tumor adhesion
renal cancer
unclassified renal cell carcinoma
Papillary renal cell carcinoma (pRCC)
miR-146a-5p
renal cell
everolimus
integrins
cytoreductive nephrectomy
immunotherapy
predictive factors
immunohistochemistry
MTA2
IL13R?1
targeted therapy
intratumour heterogeneity
aurora A
TCA cycle
AMP-activated protein kinases
cancer-specific survival
programmed death-ligand 1
efficacy
renal cell carcinoma
anaplastic lymphoma kinase rearrangement
TFEB-amplified renal cell carcinoma
statins
cancer immunotherapy
microRNA
new entity
proteome profiling
ISBN 3-03928-639-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404087003321
López José I  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui